APA Citatie

Mavrou, A., & Oltean, S. (2016). SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing. Pharmacol Res.

Chicago Style citaat

Mavrou, Athina, en Sebastian Oltean. "SRPK1 Inhibition in Prostate Cancer: A Novel Anti-angiogenic Treatment Through Modulation of VEGF Alternative Splicing." Pharmacol Res 2016.

MLA citatie

Mavrou, Athina, en Sebastian Oltean. "SRPK1 Inhibition in Prostate Cancer: A Novel Anti-angiogenic Treatment Through Modulation of VEGF Alternative Splicing." Pharmacol Res 2016.

Let op: Deze citaties zijn niet altijd 100% accuraat.